Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asa Ericsson

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Pharmacoeconomics|April 28, 2005
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used aloneClaes-Göran Löfdahl, Asa Ericsson, Klas Svensson, et al.
Physical Review Letters|December 31, 2008
Effects of the g factor in semiclassical kinetic plasma theoryGert Brodin, Mattias Marklund, Jens Zamanian, et al.
Scandinavian Journal of Public Health|August 7, 2010
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in SwedenWilliam J Valentine, Mark Aagren, Mattias Haglund, et al.
Chest|December 12, 2002
Costs of COPD in Sweden according to disease severitySven-Arne Jansson, Fredrik Andersson, Sixten Borg, et al.
COPD|December 7, 2006
Cost differences for COPD with and without physician-diagnosisSven-Arne Jansson, Anne Lindberg, Asa Ericsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2004
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary diseaseSixten Borg, Asa Ericsson, Jadwiga Wedzicha, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 15, 2008
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohortUlf-Göran Gerdtham, L Fredrik Andersson, Asa Ericsson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Pharmacoeconomics|April 28, 2005
Cost effectiveness of budesonide/formoterol in a single inhaler for COPD compared with each monocomponent used aloneClaes-Göran Löfdahl, Asa Ericsson, Klas Svensson, et al.
Physical Review Letters|December 31, 2008
Effects of the g factor in semiclassical kinetic plasma theoryGert Brodin, Mattias Marklund, Jens Zamanian, et al.
Scandinavian Journal of Public Health|August 7, 2010
Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in SwedenWilliam J Valentine, Mark Aagren, Mattias Haglund, et al.
Chest|December 12, 2002
Costs of COPD in Sweden according to disease severitySven-Arne Jansson, Fredrik Andersson, Sixten Borg, et al.
COPD|December 7, 2006
Cost differences for COPD with and without physician-diagnosisSven-Arne Jansson, Anne Lindberg, Asa Ericsson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 29, 2004
A computer simulation model of the natural history and economic impact of chronic obstructive pulmonary diseaseSixten Borg, Asa Ericsson, Jadwiga Wedzicha, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 15, 2008
Factors affecting chronic obstructive pulmonary disease (COPD)-related costs: a multivariate analysis of a Swedish COPD cohortUlf-Göran Gerdtham, L Fredrik Andersson, Asa Ericsson, et al.
Pageof 1